515 related articles for article (PubMed ID: 17122008)
21. Comparison of Aptima and hybrid capture-2 HPV tests and Pap test in the referral population in Japan.
Kuroki H; Sakamoto J; Shibata T; Takakura M; Sasagawa T
J Med Virol; 2021 Aug; 93(8):5076-5083. PubMed ID: 33634473
[TBL] [Abstract][Full Text] [Related]
22. A comparison of the clinical utility of p16(INK4a) immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia/neoplasia.
Holladay EB; Logan S; Arnold J; Knesel B; Smith GD
Cancer; 2006 Dec; 108(6):451-61. PubMed ID: 17078096
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the clinical performances of the AdvanSure HPV Screening Real-Time PCR, the Abbott Real-Time High-Risk HPV Test, and the Hybrid Capture High-Risk HPV DNA Test for Cervical Cancer Screening.
Chung HS; Hahm C; Lee M
J Virol Methods; 2014 Sep; 205():57-60. PubMed ID: 24814874
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus (HPV) in atypical squamous cervical cytology: the Invader HPV test as a new screening assay.
Wong AK; Chan RC; Nichols WS; Bose S
J Clin Microbiol; 2008 Mar; 46(3):869-75. PubMed ID: 18174309
[TBL] [Abstract][Full Text] [Related]
25. The PapilloCheck Assay for Detection of High-Grade Cervical Intraepithelial Neoplasia.
Crosbie EJ; Bailey A; Sargent A; Gilham C; Peto J; Kitchener HC
J Clin Microbiol; 2015 Nov; 53(11):3553-9. PubMed ID: 26338859
[TBL] [Abstract][Full Text] [Related]
26. Comparison Study of BD Onclarity HPV With digene HC2 High-Risk HPV DNA Test and Roche Cobas 4800 HPV for Detecting High-Risk Human Papillomavirus in Japan.
Nakamura M; Nakade K; Orisaka S; Iwadare J; Mizumoto Y; Fujiwara H
Am J Clin Pathol; 2019 Feb; 151(3):263-269. PubMed ID: 30260388
[TBL] [Abstract][Full Text] [Related]
27. Comparison of AMPLICOR and Hybrid Capture II assays for high risk HPV detection in normal and abnormal liquid-based cytology: use of INNO-LiPA Genotyping assay to screen the discordant results.
Mo LZ; Monnier-Benoit S; Kantelip B; Petitjean A; Riethmuller D; Prétet JL; Mougin C
J Clin Virol; 2008 Feb; 41(2):104-10. PubMed ID: 18036888
[TBL] [Abstract][Full Text] [Related]
28. Clinical performance of the CLART human papillomavirus 2 assay compared with the hybrid capture 2 test.
Pista A; Verdasca N; Oliveira A
J Med Virol; 2011 Feb; 83(2):272-6. PubMed ID: 21181922
[TBL] [Abstract][Full Text] [Related]
29. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Onclarity Human Papillomavirus (HPV) Assay with Hybrid Capture II HPV DNA Assay for Detection of Cervical Intraepithelial Neoplasia Grade 2 and 3 Lesions.
Bottari F; Sideri M; Gulmini C; Igidbashian S; Tricca A; Casadio C; Carinelli S; Boveri S; Ejegod D; Bonde J; Sandri MT
J Clin Microbiol; 2015 Jul; 53(7):2109-14. PubMed ID: 25903574
[TBL] [Abstract][Full Text] [Related]
31. Anyplex II HPV test in detection and follow-up after surgical treatment of CIN2+ lesions.
Bottari F; Iacobone AD; Radice D; Preti EP; Preti M; Franchi D; Piana AF; Sandri MT; Passerini R
J Med Virol; 2021 Nov; 93(11):6340-6346. PubMed ID: 33565607
[TBL] [Abstract][Full Text] [Related]
32. Head-to-Head Comparison of DH3 HPV Test and HC2 Assay for Detection of High-Risk HPV Infection in Residual Cytology Samples from Cervical Cancer Screening Setting: Baseline and 3-Year Longitudinal Data.
Fu Y; Li X; Li Y; Lu W; Xie X; Wang X
Microbiol Spectr; 2022 Feb; 10(1):e0157021. PubMed ID: 35171029
[TBL] [Abstract][Full Text] [Related]
33. Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.
Cornall AM; Poljak M; Garland SM; Phillips S; Tan JH; Machalek DA; Quinn MA; Tabrizi SN
Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):545-551. PubMed ID: 27822653
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; Guimerà N; Torne A; Ordi J
J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
[TBL] [Abstract][Full Text] [Related]
35. Clinical performance of the BD Onclarity HPV assay using an adjudicated cohort of BD SurePath liquid-based cytology specimens.
Wright TC; Stoler MH; Agreda PM; Beitman GH; Gutierrez EC; Harris JM; Koch KR; Kuebler M; LaViers WD; Legendre BL; Leitch SV; Maus CE; McMillian RA; Nussbaumer WA; Palmer ML; Porter MJ; Richart GA; Schwab RJ; Vaughan LM
Am J Clin Pathol; 2014 Jul; 142(1):43-50. PubMed ID: 24926084
[TBL] [Abstract][Full Text] [Related]
36. Comparative evaluation of three commercial systems for detection of high-risk human papillomavirus in cervical and vaginal ThinPrep PreservCyt samples and correlation with biopsy results.
Binnicker MJ; Pritt BS; Duresko BJ; Espy MJ; Grys TE; Zarka MA; Kerr SE; Henry MR
J Clin Microbiol; 2014 Oct; 52(10):3763-8. PubMed ID: 25122861
[TBL] [Abstract][Full Text] [Related]
37. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia.
Monsonego J; Pintos J; Semaille C; Beumont M; Dachez R; Zerat L; Bianchi A; Franco E
Int J Gynecol Cancer; 2006; 16(2):591-8. PubMed ID: 16681731
[TBL] [Abstract][Full Text] [Related]
39. Assessment of fluorescence in situ hybridization and hybrid capture 2 analyses of cervical cytology specimens diagnosed as low grade squamous intraepithelial lesion for the detection of high grade cervical intraepithelial neoplasia.
Voss JS; Kipp BR; Campion MB; Sokolova IA; Henry MR; Halling KC; Clayton AC
Anal Quant Cytol Histol; 2010 Jun; 32(3):121-30. PubMed ID: 20701064
[TBL] [Abstract][Full Text] [Related]
40. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
